Granules India gets USFDA nod for overactive bladder treatment capsule
Posted by
www.biotecnika.org
"The US Food and Drug Administration (USFDA) has approved the
abbreviated new drug application filed by Granules Pharmaceuticals,
Inc, a wholly owned foreign subsidiary of Granules India Ltd, for
Trospium Chloride extended-release capsules, 60 mg," the company said
in a regulatory filing.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/granules-india-gets-usfda-nod-for-overactive-bladder-treatment-capsule/articleshow/75344959.cms
Subscribe to:
Post Comments (Atom)
Post a Comment